Jason M. Tanner
No Rating Available
(Learn About Our Rating System)

Jason M. Tanner, MD, PhD

Languages spoken: English, Spanish

Clinical Locations

Primary Location

University of Utah Hospital

Emergency Medicine
50 N Medical Dr
Salt Lake City , UT 84132
801-581-2121
Get Directions

South Jordan Health Center

5126 West Daybreak Parkway
South Jordan , UT 84009
801-213-4500
Get Directions

  • Dr. Jason Tanner is an Assistant Professor of Emergency Medicine with a dedicated focus on both cutting-edge molecular research and practical medical applications in challenging environments. His interests include studying molecular derangements present in emergent conditions including stroke, sepsis, and trauma.

    Dr. Tanner is also passionate about wilderness and austere medicine, and collaborates with search and rescue teams and EMS providers to develop innovative approaches for delivering high-quality medical care in remote and resource-constrained settings.

    Specialties

  • Dr. Jason Tanner is an Assistant Professor of Emergency Medicine with a dedicated focus on both cutting-edge molecular research and practical medical applications in challenging environments. His interests include studying molecular derangements present in emergent conditions including stroke, sepsis, and trauma.

    Dr. Tanner is also passionate about wilderness and austere medicine, and collaborates with search and rescue teams and EMS providers to develop innovative approaches for delivering high-quality medical care in remote and resource-constrained settings.

    Board Certification and Academic Information

    Academic Departments Eccles Health Library -Assistant Professor

    Education history

    Undergraduate International Studies - University of Utah B.A.
    Doctoral Training Biochemistry - University of Utah Ph.D.
    Professional Medical Medicine - University of Utah School of Medicine M.D.
    Residency Emergency Medicine - Yale School of Medicine Resident
    Fellowship Wilderness Medicine - Yale School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Chartash D, Sharifi M, Emerson B, Frank R, Schoenfeld EM, Tanner J, Brandt C, Taylor R (2021). Documentation of Shared Decisionmaking in the Emergency Department. Annals of emergency medicine, 78(5), 637-649. (Read full publication)
    2. Theisen ER, Selich-Anderson J, Miller KR, Tanner JM, Taslim C, Pishas KI, Sharma S, Lessnick S (2021). Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein. Epigenetics, 16(4), 405-424. (Read full publication)
    3. Bensard CL, Wisidagama DR, Olson KA, Berg JA, Krah NM, Schell JC, Nowinski SM, Fogarty S, Bott AJ, Wei P, Dove KK, Tanner JM, Panic V, Cluntun A, Lettlova S, Earl CS, Namnath DF, Vázquez-Arreguín K, Villanueva CJ, Tantin D, Murtaugh LC, Evason KJ, Ducker GS, Thummel CS, Rutter (2020). Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier. Cell metabolism, 31(2), 284-300.e7. (Read full publication)
    4. Tanner JM, Bensard C, Wei P, Krah NM, Schell JC, Gardiner J, Schiffman J, Lessnick SL, Rutter (2017). EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma. Molecular cancer research, 15(11), 1517-1530. (Read full publication)
    5. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter (2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nature cell biology, 19(9), 1027-1036. (Read full publication)
    6. Sankar S, Tanner JM, Bell R, Chaturvedi A, Randall RL, Beckerle MC, Lessnick S (2013). A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma. Molecular and cellular biology, 33(22), 4448-60. (Read full publication)
    7. Zhang QJ, Holland WL, Wilson L, Tanner JM, Kearns D, Cahoon JM, Pettey D, Losee J, Duncan B, Gale D, Kowalski CA, Deeter N, Nichols A, Deesing M, Arrant C, Ruan T, Boehme C, McCamey DR, Rou J, Ambal K, Narra KK, Summers SA, Abel ED, Symons J (2012). Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes, 61(7), 1848-59. (Read full publication)
    8. Tanner JM, Kearns DT, Kim BJ, Sloan C, Jia Z, Yang T, Abel ED, Symons J (2010). Fasting-induced reductions in cardiovascular and metabolic variables occur sooner in obese versus lean mice. Experimental biology and medicine (Maywood, N.J.), 235(12), 1489-97. (Read full publication)
    9. Zhang QJ, McMillin SL, Tanner JM, Palionyte M, Abel ED, Symons J (2009). Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: role of vascular signalling kinases. The Journal of physiology, 587(Pt 15), 3911-20. (Read full publication)
    10. Symons JD, McMillin SL, Riehle C, Tanner J, Palionyte M, Hillas E, Jones D, Cooksey RC, Birnbaum MJ, McClain DA, Zhang QJ, Gale D, Wilson LJ, Abel E (2009). Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circulation research, 104(9), 1085-94. (Read full publication)

    Commentary

    1. Tanner JM, Rutter (2016). You Are What You Eat... or Are You?. Developmental cell, 36(5), 483-5. (Read full publication)